The fibrosis of ketamine, a noncompetitive N-methyl-D-aspartic acid receptor antagonist dose-dependent change in a ketamine-induced cystitis rat model

Drug and Chemical Toxicology

Volumn 39, Issue 2, 2016, Pages 206-212

  Song, Miho ^a,b   Yu, Hwan Yeul ^b   Chun, Ji Youn ^b   Shin, Dong Myung ^b   Song, Soo Hyun ^c   Choo, Myung Soo ^b   Song, Yun Seob ^a  

^a Soonchunhyang University   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Yonsei University   (South Korea)

Author keywords

Apoptosis; cystitis; cystometry; fibrosis; ketamine

Indexed keywords

ALPHA4 INTEGRIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; KETAMINE; PROTEIN BAX; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; AMINO ACID RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLADDER CAPACITY; BLADDER COMPLIANCE; BLADDER DISEASE; BLADDER DYSFUNCTION; BLADDER FIBROSIS; BLADDER FUNCTION; CONTROLLED STUDY; CYSTITIS; CYSTOMETRY; DOSE RESPONSE; FEMALE; FIBROGENESIS; FIBROSIS; HISTOLOGY; IMMUNOHISTOCHEMISTRY; LOWER URINARY TRACT SYMPTOM; NONHUMAN; PATHOPHYSIOLOGY; QUANTITATIVE ANALYSIS; RAT; RAT MODEL; REAL TIME POLYMERASE CHAIN REACTION; RESIDUAL URINE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; URODYNAMICS; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; CYSTITIS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; FIBROSIS; KETAMINE; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; URODYNAMICS;

EID: 84957962954     PISSN: 01480545     EISSN: 15256014     Source Type: Journal    
DOI: 10.3109/01480545.2015.1079916     Document Type: Article

References (32)

1. Chatterjee M, Ganguly S, Srivastava M, et al. (2011). Effect of 'chronic' versus 'acute' ketamine administration and its 'with-drawal' effect on behavioural alterations in mice: Implications for experimental psychosis. Behav Brain Res 216:247-254.
2. Chen CC, Lau LF. (2010). Deadly liaisons: Fatal attraction between CCN matricellular proteins and the tumor necrosis factor family of cytokines. J Cell Commun Signal 4:63-69.
3. Chiew YW, Yang CS. (2009). Disabling frequent urination in a young adult. Ketamine-associated ulcerative cystitis. Kidney Int 76:123-124.
4. Chu PS, Kwok SC, Lam KM, et al. (2007). 'Street ketamine'-associated bladder dysfunction: A report of ten cases. Hong Kong Med J 13:311-313.
5. Chu PS, Ma WK, Wong SC, et al. (2008). The destruction of the lower urinary tract by ketamine abuse: A new syndrome? BJU Int 102:1616-1622.
6. Colebunders B, Van Erps P. (2008). Cystitis due to the use of ketamine as a recreational drug: A case report. J Med Case Rep 2:219.
7. Craven R. (2007). Ketamine. Anaesthesia 62(Suppl 1):48-53.
8. Dillon P, Copeland J, Jansen K. (2003). Patterns of use and harms associated with non-medical ketamine use. Drug Alcohol Depend 69:23-28.
9. Gu D, Huang J, Shan Z. (2013). Effects of long-term ketamine administration on rat bladder protein levels: A proteomic investigation using two-dimensional difference gel electrophoresis system. Int J Urol 20:1024-1031.
10. Haas DA, Harper DG. (1992). Ketamine: A review of its pharmacologic properties and use in ambulatory anesthesia. Anesth Prog 39:61-68.
11. Harrison NL, Simmonds MA. (1985). Quantitative studies on some antagonists of N-methyl D-aspartate in slices of rat cerebral cortex. Br J Pharmacol 84:381-391.
12. Ikonomidou C, Bosch F, Miksa M, et al. (1999). Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 283:70-74.
13. Irifune M, Sato T, Kamata Y, et al. (2000). Evidence for GABA(A) receptor agonistic properties of ketamine: convulsive and anesthetic behavioral models in mice. Anesth Analg 91:230-236.
14. Jang MY, Long CY, Chuang SM, et al. (2012). Sexual dysfunction in women with ketamine cystitis: A case-control study. BJU Int 110:427-431.
15. Joe Laidler KA. (2005). The rise of club drugs in a heroin society: The case of Hong Kong. Subst Use Misuse 40:1257-1278.
16. Johnson A, DiPietro LA. (2013). Apoptosis and angiogenesis: An evolving mechanism for fibrosis. FASEB J 27:3893-3901.
17. Lankenau SE, Sanders B. (2007). Patterns of ketamine use among young injection drug users. J Psychoactive Drugs 39:21-29.
18. Lankenau SE, Sanders B, Bloom JJ, et al. (2007). First injection of ketamine among young injection drug users (IDUs) in three U.S. cities. Drug Alcohol Depend 87:183-193.
19. Lee CL, Jiang YH, Kuo HC. (2013). Increased apoptosis and suburothelial inflammation in patients with ketamine-related cystitis: A comparison with non-ulcerative interstitial cystitis and controls. BJU Int 112:1156-1162.
20. Li WP, Chan WY, Lai HW, et al. (1997). Terminal dUTP nick end labeling (TUNEL) positive cells in the different regions of the brain in normal aging and Alzheimer patients. J Mol Neurosci 8:75-82.
21. Meng E, Chang HY, Chang SY, et al. (2011). Involvement of purinergic neurotransmission in ketamine induced bladder dysfunction. J Urol 186:1134-1141.
22. Mason K, Cottrell AM, Corrigan AG, et al. (2010). Ketamine-associated lower urinary tract destruction: A new radiological challenge. Clin Radiol 65:795-800.
23. Shahani R, Streutker C, Dickson B, et al. (2007). Ketamine-associated ulcerative cystitis: A new clinical entity. Urology 69:810-812.
24. Shen CH, Wang ST, Lee Y, et al. (2015). Biological effect of ketamine in urothelial cell lines and global gene expression analysis in the bladders of ketamine-injected mice. Mol Med Rep 11:887-895.
25. Shin DM, Zuba-Surma EK, Wu W, et al. (2009). Novel epigenetic mechanisms that control pluripotency and quiescence of adult bone marrow-derived Oct4(+) very small embryonic-like stem cells. Leukemia 23:2042-2051.
26. Song M, Heo J, Chun JY, et al. (2014). The paracrine effects of mesenchymal stem cells stimulate the regeneration capacity of endogenous stem cells in the repair of a bladder-outlet-obstruction-induced overactive bladder. Stem Cells Dev 23:654-663.
27. Tsai TH, Cha TL, Lin CM, et al. (2009). Ketamine-associated bladder dysfunction. Int J Urol 16:826-829.
28. Wang L, Scabilloni JF, Antonini JM, et al. (2006). Induction of secondary apoptosis, inflammation, and lung fibrosis after intratracheal instillation of apoptotic cells in rats. Am J Physiol Lung Cell Mol Physiol 290:L695-L702.
29. White PF, Way WL, Trevor AJ. (1982). Ketamine - Its pharmacology and therapeutic uses. Anesthesiology 56:119-136.
30. Wood D, Cottrell A, Baker SC, et al. (2011). Recreational ketamine: From pleasure to pain. BJU Int 107:1881-1884.
31. Xu Q, Ming X, Dar AM, et al. (2007). Optimizing dosage of ketamine and xylazine in murine echocardiography. Clin Exp Pharmacol Physiol 34:499-507.
32. Yeung LY, Rudd JA, Lam WP, et al. (2009). Mice are prone to kidney pathology after prolonged ketamine addiction. Toxicol Lett 191:275-278.